Log In
Print
BCIQ
Print
Print this Print this
 

Memantine ER/donepezil (ADS-8704, MDX-8704)

Also known as: Arimenda

  Manage Alerts
Collapse Summary General Information
Company Adamas Pharmaceuticals Inc.
DescriptionFixed dose combination of extended release memantine and donepezil
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat moderate to severe Alzheimer's dementia
Regulatory Designation

Partner

Forest Laboratories Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today